Announcements Trials
Browse Landscape

Phase

Phase 2 110Phase 3 68Phase 1 49Phase 1/2 33Phase NA 9Phase 2/3 8Phase 4 3

Status

Unknown 1Terminated 1Completed 1

Sponsor Class

OTHER 2UNKNOWN 1

Study Type

Interventional 3

Sponsor

Cancer Type

Other hematologic neoplasm 3

Conditions

Precursor Cell Lymphoblastic Leukemia-Lymphoma 19Leukemia, Myeloid, Acute 11Neoplasm, Residual 3Leukemia 3Recurrence 2Leukemia, Promyelocytic, Acute 2Burkitt Lymphoma 2Myelodysplastic Syndromes 1Meningitis 1Meningeal Neoplasms 1Mediastinal Neoplasms 1Lymphoma, Non-Hodgkin 1Lymphoma, Mantle-Cell 1Lymphoma, Large-Cell, Anaplastic 1Lymphoma, Large B-Cell, Diffuse 1Lymphoma 1Leukemia, Biphenotypic, Acute 1

Interventions

nilotinib 4Cytarabine 3Filgrastim 2Cyclophosphamide 2Aprepitant 2Antilymphocyte Serum 2rasburicase 1liposomal amphotericin B 1fludarabine phosphate 1fludarabine 1bosutinib 1blinatumomab 1aldesleukin 1Water 1Voriconazole 1Urate Oxidase 1Tobacco Use Cessation Devices 1Thiotepa 1Rituximab 1Radiotherapy 1Psychiatric Rehabilitation 1Prilocaine 1Polymerase Chain Reaction 1Pharmacogenomic Testing 1Pentostatin 1Palonosetron 1Oxygen 1Interleukin-2 1Inotuzumab Ozogamicin 1Histamine 1

Date Range

30 days90 days1 yearAll

Options

Has results Has announcements

Clinical Trials

3 trials
RecentStart dateEnrollment
Phase 4 × Leukemia × Cytarabine × Clear all
NCT03988205 2022-07-19

Patients Receiving Induction With Liposomal Daunorubicin and Cytarabine (CPX-351) for Acute Myeloid Leukemia

Medical College of Wisconsin

Phase 4 Terminated
3 enrolled 10 charts
Other hematologic neoplasm

Leukemia, Leukemia, Myeloid, Acute

NCT01191541 2021-08-10

Ara-C

ChineseAMS

Phase 4 Completed
65 enrolled 8 charts
Other hematologic neoplasm

Leukemia

NCT02784561 2016-05-27

Study of Busulfan and FLAG Conditioning Regimen for Allogeneic Peripheral Blood Stem Cell Transplantation

Chinese PLA General Hospital

Phase 4 Unknown
80 enrolled
Other hematologic neoplasm

Leukemia, Recurrence

Data powered by HemOnc (CC BY 4.0) Colophon âš¡